drugset / Trial / NCT05931224

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

NCT05931224

Phase 3 Completed 346 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Timeline

Start
2023-06-28
Primary completion
2024-05-13
Completion
2024-05-13

Drugs

EvaluationDrugModalityDoseRoute
Subject D064 Unknown
Subject D660 Unknown
Subject D702 Unknown